VSH · Vishay Intertechnology, Inc. · Stock research

Current Thesis

The cyclical re-rate has fully unwound. Vishay's Q1 2026 print on 2026-05-13 was genuine — $839.2M revenue against ~$822.8M consensus, EPS $0.05 vs $0.03, a 1.34 book-to-bill and a $1.6B backlog covering 5.7 months — and the stock ran to $69.47 on it. Management then priced 15M shares at $50 on 2026-06-30 for ~$750M gross, and the tape has that level: after down sessions of -8.6% (2026-07-07, $42.19), -6.1% (2026-07-13, $41.94) and -7.4% (2026-07-16, $37.46), the stock printed $35.67 intraday on 2026-07-16 and closed 2026-07-17 near $37.81 — off 36.4% in a month and 45.6% from the high, below the placement price and below every covering analyst's target. What remains is a discrete-components cyclical at roughly 35x forward earnings heading into a 2026-08-05 Q2 report that will confirm or break the recovery. Strength was the reason to own it in May; the surrendered structure is the reason to stand aside now until that print clears.

Bullish and bearish views on Vishay Intertechnology, Inc.

The model's bull view on Vishay Intertechnology, Inc. (VSH), in brief: Q1 2026 (2026-05-13): revenue $839.2M vs ~$822.8M consensus and EPS $0.05 vs $0.03; a 1.34 book-to-bill with a $1.6B backlog at 5.7 months of coverage is order strength a single restock quarter does not produce. The bear view: Price has round-tripped the entire re-rate: -36.4% in a month, -45.6% from $69.47, and now beneath the $50 placement. Both cases follow in full.

Bull Case

• Q1 2026 (2026-05-13): revenue $839.2M vs ~$822.8M consensus and EPS $0.05 vs $0.03; a 1.34 book-to-bill with a $1.6B backlog at 5.7 months of coverage is order strength a single restock quarter does not produce.
• Q2 guidance issued 2026-05-13 at $875M–$905M sits above the ~$858M Street mark; the $890M midpoint implies ~6% sequential growth off $839.2M.
• Demand breadth cited on the Q1 call spans automotive, industrial, aerospace-defense and power applications, with distribution-channel sell-through leading — a widening recovery rather than one concentrated end-market.
• The $750M raise (2026-06-30) is earmarked for growth capex and debt reduction; two additional subcontractors were qualified in Q1 for rectifiers and aluminum capacitors, adding capacity against the backlog rather than rationing it.
• CMMC Level 2 certification supports secure participation in U.S. defense programs, reinforcing the aerospace-defense content mix.
• Positioning is already bearish: the most recent rating is a Sell at $28 (BofA Underperform, raised from $18 on 2026-05-14), and the broad analyst target set (~$28–34) sits under spot. A clean 2026-08-05 beat would land against consensus that has stopped expecting one.

Bear Case

• Price has round-tripped the entire re-rate: -36.4% in a month, -45.6% from $69.47, and now beneath the $50 placement. The orderly sequence of -8.6% / -6.1% / -7.4% sessions into 2026-07-16 reads as distribution rather than a single-headline shock.
• The offering is the clearest read on management's own view of value — selling ~10% of the company at $50 while the tape was in the mid-$50s signals the insider mark on the multiple sat below the print.
• Margin has not tracked volume. Q2 gross-margin guidance of ~22.0% is well under the 30%+ historical band, and the medium-term margin path carries elevated materials cost and tariff exposure.
• Valuation still has compression room: ~35.5x forward earnings on a ~$5.80B market cap, against 2025 revenue of $3.07B (+4.5%) and a 2025 net loss of $8.98M, is a growth multiple on a components cyclical.
• Macro turned against the theme: a report of SK Hynix slowing AI-memory capacity expansion trimmed the data-center-power narrative, and hawkish Fed repricing pushed market-implied odds of a second 2026 hike to ~85% from ~60% — a direct hit to industrial-capex multiples.
• The 15M freshly placed shares from 2026-06-30 sit as overhang on any rally back toward $50.

Setup & Price Structure

Structure is broken across timeframes. The advance from the low-$30s pre-Q1 base to $69.47 has been fully retraced; the June placement at $50 now acts as resistance rather than support, and the mid-$30s — the $35.67 intraday low of 2026-07-16 — is the line the tape is testing. Price sits below the placement, below the midpoint of the ~$28–34 analyst target band, and below the falling short-term moving averages implied by three consecutive >6% down sessions. A weekly close under $35 confirms the round-trip and exposes the pre-Q1 congestion in the high $20s, where the broader desk set (~$28.56 average across roughly ten analysts) is anchored. The higher-quality continuation entry is not a knife-catch into the print but a reclaim: a weekly close back above the 20-EMA with positive relative strength versus SOXX over 20 sessions. Options flow flagged unusual activity on 2026-07-21 (whale-alert scan) — worth watching for directional positioning into 2026-08-05, not a directional signal on its own.

Catalyst Calendar (next 30 days)

No upcoming dated catalysts on file — the dated entries below have passed.

Elapsed catalysts

• 2026-08-05 (confirmed): Q2 2026 results for the fiscal quarter ended 2026-07-04, before the NYSE open, conference call 9:00 a.m. ET. The binary — revenue against the $875–905M guide, book-to-bill continuity above or below 1.0, and gross-margin trajectory off the ~22% guide. (passed 4d ago)
• ~2026-07-31 through 2026-08-04: the three trading sessions ahead of the print carry binary risk; no clean fresh-entry window exists here. (passed 5d ago)
• ~2026-08-04 (est.): peer analog/discrete prints (e.g., ON Semiconductor) set the auto/industrial read-through into VSH's own number — a peer Q2 auto-guide cut argues against anticipating the turn. (passed 5d ago)
• Ongoing: placement-share overhang from the 2026-06-30 offering and any post-print analyst target revisions off the current ~$28–34 band. (passed 40d ago)

What Would Change Our Mind

• A constructive flip needs a 2026-08-05 print with revenue at or above the $890M midpoint, book-to-bill holding above 1.0, and gross margin inflecting off ~22% toward the mid-20s; volume without margin does not re-rate a 35x multiple.
• On price, a weekly close back above the 20-EMA with positive RS versus SOXX over 20 sessions, plus reclaiming the $50 placement level, would signal the overhang has been absorbed.
• Sell-side turning: the current Sell-at-$28 mark being lifted, or the ~$28–34 target band raised through spot, would confirm narrative re-acceleration rather than a dead-cat bounce.
• The downside confirmation, conversely, is a weekly close below $35 or a Q2 book-to-bill back under 1.0 — either resolves the cyclical thesis lower and points at the high-$20s.

Correlation Notes

• VSH trades as an analog/discrete-components cyclical, correlated with SOXX and with auto/industrial semiconductor peers (Texas Instruments, ON Semiconductor, STMicroelectronics, Analog Devices); its reaction to the print will be amplified by whatever those peers guide first.
• Rate-sensitive through the industrial-capex channel: the shift to ~85% implied odds of a second 2026 hike compresses the multiple independent of company execution.
• End-market drivers are automotive production, industrial capex and aerospace-defense content, not AI compute. VSH carries power-side exposure — capacitor banks and power management into grid, EV and data-center power, company-cited on the Q1 call — but zero HBM/memory/compute content; the SK Hynix capacity-slowdown read-through is second-order, and the name should not be grouped with AI-memory infrastructure.
• The 2026-06-30 equity issuance adds an idiosyncratic supply factor that decouples near-term price action from the peer group until the placed shares are absorbed.